SRPX2 regulates colon cancer cell metabolism by miR-192/215 via PI3K-Akt

被引:9
|
作者
Zhao, Jian [1 ]
Xu, Jian [1 ]
Zhang, Rui [1 ]
机构
[1] China Med Univ, Liaoning Canc Hosp & Inst, Canc Hosp, Dept Colorectal Surg, 44 Xiaoheyan Rd, Shenyang 110042, Liaoning, Peoples R China
来源
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2018年 / 10卷 / 02期
关键词
SRPX2; miR-192; miR-215; colon cancer; PI3K-Akt; GASTRIC-CANCER; COLORECTAL-CANCER; MICRORNA-192; SUPPRESSES; MIR-215; GLIOBLASTOMA; PROGRESSION; METASTASIS; EXPRESSION; DISORDERS; PROGNOSIS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colon cancer is one of common cancer in the world and glycolysis is one of the major problems in colon cancer therapy. MicroRNAs (miRNAs) involve in colon cancer progression. Sushi repeat-containing protein X-linked 2 (SRPX2) is associated with poor prognosis in some cancer patients, however, the role of SRPX2 including glycolytic metabolism regulated by miRNAs is unclear in colon cancer. So, the purpose of the present study is to elucidate the underlying mechanism in colon cancer metabolism mediated by SRPX2. Our results revealed that miR-192-5p (miR-192) and miR-215-5p (miR-215) inhibited glycolysis by regulating SRPX2 expression in colon cancer cells. We also found that miR-192 and miR-215 were both regulated by PI3K-Akt. Our results indicate that SRPX2 facilitates colon cancer cell glycolysis by miR-192 and miR-215, which are down-regulated by PI3K-Akt.
引用
收藏
页码:483 / 490
页数:8
相关论文
共 50 条
  • [31] Mitotic checkpoint kinase Mps1/TTK predicts prognosis of colon cancer patients and regulates tumor proliferation and differentiation via PKCα/ERK1/2 and PI3K/Akt pathway
    Zhang, Li
    Jiang, Baofei
    Zhu, Ni
    Tao, Mingyue
    Jun, Yali
    Chen, Xiaofei
    Wang, Qilong
    Luo, Chao
    MEDICAL ONCOLOGY, 2020, 37 (01)
  • [32] NECTIN-4 increased the 5-FU resistance in colon cancer cells by inducing the PI3K-AKT cascade
    Das, Dipon
    Satapathy, Shakti Ranjan
    Siddharth, Sumit
    Nayak, Anmada
    Kundu, Chanakya Nath
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (03) : 471 - 479
  • [33] The adenosine-A2a receptor regulates the radioresistance of gastric cancer via PI3K-AKT-mTOR pathway
    Liu, Guihong
    Yang, Song
    Liu, Yang
    Xu, Yumei
    Qiu, Hui
    Sun, Jian
    Song, Jun
    Shi, Linsen
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (05) : 911 - 920
  • [34] PHLDA2 regulates EMT and autophagy in colorectal cancer via the PI3K/AKT signaling pathway
    Ma, Zhan
    Lou, Shuping
    Jiang, Zheng
    AGING-US, 2020, 12 (09): : 7985 - 8000
  • [35] GRP78 Secreted by Colon Cancer Cells Facilitates Cell Proliferation via PI3K/Akt Signaling
    Fu, Rong
    Yang, Peng
    Wu, Hai-Li
    Li, Zong-Wei
    Li, Zhuo-Yu
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (17) : 7245 - 7249
  • [36] Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer
    Chen, Xu
    Wang, Ya-Wen
    Xing, Ai-Yan
    Xiang, Shuai
    Shi, Duan-Bo
    Liu, Lei
    Li, Yan-Xiang
    Gao, Peng
    JOURNAL OF PATHOLOGY, 2016, 239 (04) : 459 - 472
  • [37] Knockdown of LINC02465 Suppresses Gastric Cancer Cell Growth and Metastasis Via PI3K/AKT Pathway
    Han, Liang
    Hao, Yanping
    Wang, Jianhua
    Wang, Zhengjiang
    Yang, Hongmei
    Wu, Xudong
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2019, 30 (01) : 19 - 28
  • [38] HBXIP Regulates Gastric Cancer Glucose Metabolism and Malignancy Through PI3K/AKT and p53 Signaling
    Qiu, Lei
    Lu, Feng
    Zhang, Lili
    Wang, Gang
    Geng, Rui
    Miao, Yongchang
    ONCOTARGETS AND THERAPY, 2020, 13 : 3359 - 3374
  • [39] Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling
    Ma, Jiachi
    Sun, Xiaowen
    Wang, Yimin
    Chen, Bangling
    Qian, Liyu
    Wang, Yaguo
    CELL COMMUNICATION AND SIGNALING, 2019, 17 (01)
  • [40] LncRNA MALAT1 Promotes Cancer Metastasis in Osteosarcoma via Activation of the PI3K-Akt Signaling Pathway
    Chen, Yong
    Huang, Wending
    Sun, Wei
    Zheng, Biqiang
    Wang, Chunmeng
    Luo, Zhiguo
    Wang, Jian
    Yan, Wangjun
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 51 (03) : 1313 - 1326